equity investment
Cystic Fibrosis Foundation Invests $2.3M in Owlstone Medical
The firm will develop an assay to detect and monitor Pseudomonas aeruginosa infection in patients with cystic fibrosis.
With $13 million in new funding in hand, the small bioinformatics company aims to take on Big Pharma and will look to partner with major molecular labs.
Prenetics to Take Majority Stake in ACT Genomics
ACT provides a range of genomic testing services for major solid tumor types, as well as biomarker discovery and company diagnostic development services.
Microba Life Sciences to Sell 20 Percent Stake to Sonic Healthcare
The companies are also finalizing a strategic alliance to distribute Microba's microbiome testing products in a number of international markets.
Immucor, Pirche Partner to Embed Epitope Matching Prediction Pipeline into Transplant Dx Software
An unspecified investment will give Immucor exclusive access to PIRCHE scores and embedded visualizations for HLA antibody analysis.